mic_none

Portal:Viruses Source: en.wikipedia.org/wiki/Portal:Viruses


The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Cold sore on the lower lip (arrow)
Cold sore on the lower lip (arrow)

Herpes simplex is caused by herpes simplex virus types 1 and 2 of the Herpesviridae family, with 60–95% of adults being infected with one of the types. Common forms of infection are oral herpes, which can result in cold sores, and genital herpes. Active disease often involves blisters containing infectious virus, although the genital form is frequently asymptomatic. Less common disorders associated with the viruses include herpetic whitlow, herpes gladiatorum, ocular herpes, herpesviral encephalitis and Mollaret's meningitis.

After initial infection, virus particles are transported along sensory nerves to the cell bodies in the ganglion, where they become latent and remain lifelong. Periods of remission alternate with outbreaks of active disease, in which the virus multiplies in the nerve cell and new virus particles are transported along the nerve fibre to the nerve terminals in the skin, where they are released. What causes these recurrences is unclear. Transmission is usually by direct contact with a lesion or with body fluids, and can occur during periods of asymptomatic shedding. Neonatal herpes is possible after transmission from the mother. Barrier protection methods reduce genital herpes risk. No vaccine or cure exists, but antiviral treatment can alleviate symptoms and reduce viral shedding.

Selected image

Ribbon diagram showing T7 RNA polymerase (blue) making messenger RNA (green) based on a DNA template (orange)

Some viruses, such as the T7 bacteriophage, encode their own RNA polymerase, the enzyme that makes messenger RNA based on a DNA template. The T7 enzyme has a single subunit, and is more like chloroplast and mitochondrial enzymes than those of bacteria or the cell.

Credit: Thomas Splettstoesser (25 June 2007)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Ribbon diagram of the Dicer enzyme from Giardia intestinalis
Ribbon diagram of the Dicer enzyme from Giardia intestinalis

RNA interference is a type of gene silencing that forms an important part of the immune response against viruses and other foreign genetic material in plants and many other eukaryotes. A cell enzyme called Dicer (pictured) cleaves double-stranded RNA molecules found in the cell cytoplasm – such as the genome of an RNA virus or its replication intermediates – into short fragments termed small interfering RNAs (siRNAs). These are separated into single strands and integrated into a large multi-protein RNA-induced silencing complex, where they recognise their complementary messenger RNA (mRNA) molecules and target them for destruction. This prevents the mRNAs acting as a template for translation into proteins, and so inhibits, or silences, the expression of viral genes.

RNA interference allows the entire plant to respond to a virus after a localised encounter, as the siRNAs can transfer between cells via plasmodesmata. The protective effect can be transferred between plants by grafting. Many plant viruses have evolved elaborate mechanisms to suppress this response. RNA interference evolved early in eukaryotes, and the system is widespread. It is important in innate immunity towards viruses in some insects, but relatively little is known about its role in mammals. Research is ongoing into the application of RNA interference to antiviral treatments.

Selected outbreak

American soldiers with influenza H1N1 at a hospital ward at Camp Funston
American soldiers with influenza H1N1 at a hospital ward at Camp Funston

The 1918–20 influenza pandemic, the first of the two involving H1N1 influenza virus, was unusually deadly. It infected 500 million people across the entire globe, with a death toll of 50–100 million (3–5% of the world's population), making it one of the deadliest natural disasters of human history. It has also been implicated in the outbreak of encephalitis lethargica in the 1920s. Despite the nickname "Spanish flu", the pandemic's geographic origin is unknown.

Most influenza outbreaks disproportionately kill young, elderly or already weakened patients; in contrast this predominantly killed healthy young adults. Contemporary medical reports suggest that malnourishment, overcrowded medical facilities and poor hygiene promoted fatal bacterial pneumonia. Some research suggests that the virus might have killed through a cytokine storm, an overreaction of the body's immune system. This would mean the strong immune reactions of young adults resulted in a more severe disease than the weaker immune systems of children and older adults.

Selected quotation

Selected virus

Structure of adeno-associated virus serotype 2

Adeno-associated viruses (AAVs) are two small DNA viruses in the Dependoparvovirus genus of the Parvoviridae family. They cannot complete their lytic replication cycle without a helper virus, which include adenoviruses, herpesviruses and vaccinia. In the absence of the helper, AAVs can integrate into the host genome at a specific site on human chromosome 19, or persist as an episome. The 20 nm icosahedral capsid lacks an envelope, and contains a single-stranded DNA genome of around 4.7 kb. AAVs infect humans and some other primates without causing disease. They generate only a mild immune response, including neutralising antibodies. The best-studied of the 11 serotypes, AAV-2, infects nerve cells, liver cells, skeletal muscle and vascular smooth muscle, using heparan sulphate proteoglycan as its primary receptor.

Its low pathogenicity makes AAV an attractive basis for viral vectors for gene therapy. Alipogene tiparvovec to treat lipoprotein lipase deficiency was the first gene therapy to be licensed, but was later withdrawn. Promising results have been obtained in early clinical trials with AAV-based gene therapy in haemophilia, congestive heart failure, spinal muscular atrophy, Parkinson's disease and the rare eye disease Leber congenital amaurosis.

Did you know?

A giant virus factory infected with Zamilon
A giant virus factory infected with Zamilon

Selected biography

Sir Frank Macfarlane Burnet (1945)

Sir Frank Macfarlane Burnet (3 September 1899 – 31 August 1985) was an Australian virologist, microbiologist and immunologist. His early virological studies were on bacteriophages, including the pioneering observation that bacteriophages could exist as a stable non-infectious form that multiplies with the bacterial host, later termed the lysogenic cycle.

With the outbreak of World War II, Burnet's focus moved to influenza. Although his efforts to develop a live vaccine proved unsuccessful, he developed assays for the isolation, culture and detection of influenza virus, including haemagglutination assays. Modern methods for producing influenza vaccines are still based on his work improving virus-growing processes in hen's eggs. He also researched influenza virus genetics, examining the genetic control of virulence and demonstrating, several years before influenza virus was shown to have a segmented genome, that the virus recombined at high frequency.

In this month

Red ribbon signifying solidarity with people living with HIV/AIDS

5 June 1981: First report of HIV/AIDS (symbol pictured) appeared in medical literature

6 June 1997: Gene silencing in plants shown to be a viral defence mechanism

7–13 June 1962: Donald Caspar and Aaron Klug proposed the quasi-equivalence principle of virus structure

7–13 June 1962: André Lwoff proposed a viral classification scheme based on nature of genome, type of symmetry and presence of envelope

7–13 June 1962: George Hirst proposed that the influenza virus genome is segmented

9 June 1981: The American Society for Virology was founded

13 June 2012: First case of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Saudi Arabia

18 June 1981: A vaccine against foot-and-mouth disease was the first genetically engineered vaccine

21 June 1996: Nevirapine approved, first NNRTI for HIV/AIDS

26 June 1993: Clinical trial of hepatitis B virus drug fialuridine terminated; the drug caused several fatalities due to lactic acidosis

28 June 2011: FAO declared rinderpest eradicated

30 June 1985: Ryan White was denied re-admittance to his school after an AIDS diagnosis, in a case that changed public perceptions of the disease

Selected intervention

Ball-and-stick model of zidovudine
Ball-and-stick model of zidovudine

Zidovudine (ZDV) (also known as AZT and sold as Retrovir) is an antiretroviral drug used in the prevention and treatment of HIV/AIDS. Classed as a nucleoside analogue reverse-transcriptase inhibitor, it inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. The first breakthrough in AIDS therapy, ZDV was licensed in 1987. While it significantly reduces HIV replication, leading to some clinical and immunological benefits, when used alone ZDV does not completely stop replication, allowing the virus to become resistant to it. The drug is therefore used together with other anti-HIV drugs in combination therapy called highly active antiretroviral therapy. To simplify its administration, ZDV is included in combination pills with lamivudine (Combivir) and lamivudine plus abacavir (Trizivir). ZDV continues to be used to prevent HIV transmission from mother to child during childbirth; it was previously part of the standard post-exposure prophylaxis after needlestick injury.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: